WIXOM, Mich., May 4, 2010 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, today announced that Robert Chioini, Chief Executive Officer, along with Dr. Richard Yocum, VP Drug Development & Medical Affairs will present at the JMP Securities Research Conference at the Ritz-Carlton Hotel in San Francisco. Dr. Ajay Gupta, Chief Scientific Officer, will be present at the conference as well.
